“…This short-term (1-2 months) human prostate primary xenograft model retains the human prostate architecture for both benign and CaP specimens and demonstrates that the progenitor stem cells respond to transplantation, androgen deprivation, and environmental signaling. Minor histological differences were observed in the human prostate xenografts, compared to the initial tissue, including inflammation, squamous metaplasia, and basal cell hyperplasia [18,19]. However, the expression of the secretory cell markers AR and PSA, basal cell marker HMW-CK, and apoptotic and proliferation indices were recapitulated in the 1-month xenograft compared to the initial specimen [18].…”